mebendazole has been researched along with alpha-Chain Disease in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghoshal, UC | 1 |
| Saha, J | 1 |
| Ghoshal, U | 1 |
| Ray, BK | 1 |
| Santra, A | 1 |
| Naik, S | 1 |
| Mazumder, DN | 1 |
1 other study available for mebendazole and alpha-Chain Disease
| Article | Year |
|---|---|
Pigmented nails and Strongyloides stercoralis infestation causing clinical worsening in a patient treated for immunoproliferative small intestinal disease: two unusual observations.
Topics: Adult; Animals; Antinematodal Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Immuno | 1999 |